Clinical Trials




Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Texas: Hot Flashes Clinical Study Participants – Women’s Health

Apply to Cedar Health to participate in a clinical study about Hot Flashes. This study is restricted to women. Hot Flashes affect women who

This Is Why We Should NEVER Rush A Vaccine To Market

We need a vaccine for Covid-19. It is a matter of life and death. At the same time, that vaccine has to be proven to be safe and effective